LifePlan Financial’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9M Buy
114,917
+2,340
+2% +$59.1K 2.03% 8
2026
Q1
$2.85M Buy
112,577
+7,370
+7% +$187K 2.11% 8
2025
Q4
$2.68M Buy
105,207
+862
+0.8% +$22K 2.05% 9
2025
Q3
$2.66M Buy
104,345
+2,005
+2% +$51K 2.11% 9
2025
Q2
$2.6M Sell
102,340
-1,205
-1% -$30.4K 2.16% 9
2025
Q1
$2.62M Buy
103,545
+3,251
+3% +$81.5K 2.28% 8
2024
Q4
$2.5M Buy
100,294
+1,808
+2% +$45.4K 2.21% 11
2024
Q3
$2.51M Buy
98,486
+1,480
+2% +$37.3K 2.16% 9
2024
Q2
$2.4M Buy
97,006
+2,065
+2% +$50.9K 2.21% 8
2024
Q1
$2.36M Buy
94,941
+3,471
+4% +$86.4K 2.17% 8
2023
Q4
$2.29M Buy
+91,470
New +$2.22M 2.3% 8

Other funds holding IBDT

LifePlan Financial's IBDT Position: Q2 2026 in Review

LifePlan Financial increased its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 2.1% in Q2 2026, buying an estimated $59.1K and bringing the position to 114,917 shares worth $2.9M. The position accounts for 2.03% of the portfolio, ranked #8.

LifePlan Financial first reported a position in IBDT in Q4 2023 and has held it in 11 quarters since. 436 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.

  • LifePlan Financial held 114,917 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $2.9M as of Q2 2026.
  • LifePlan Financial bought 2,340 iShares iBonds Dec 2028 Term Corporate ETF shares in Q2 2026, an estimated $59.1K.
  • iShares iBonds Dec 2028 Term Corporate ETF made up 2.03% of LifePlan Financial's portfolio in Q2 2026, its #8 holding.
  • LifePlan Financial first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 436 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.

Based on LifePlan Financial's 13F filing for Q2 2026, filed 21 Jul 2026.